RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)
RIAPRE is a non-interventional registry to be settled in Italy with the purpose of collecting data on 600 cases of high risk elective percutaneous coronary intervention (PCI) patients treated with an anticoagulation regime different from unfractionated heparin in monotherapy. About thirty catheterization laboratories will co-operate in this activity. The long term outcome of patients will be taken into consideration. The availability of these data will allow for a better understanding of the therapeutic needs in this area.
Drug: Bivalirudin (thrombin specific anticoagulant)
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||RIAPRE - A Non-interventional Registry on the Anticoagulation Treatment in High Risk Elective Percutaneous Coronary Interventions|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00317343
|Study Chair:||Nycomed Clinical Project Management||Headquarters|